GB0105893D0 - Pharmaceutically active compounds - Google Patents
Pharmaceutically active compoundsInfo
- Publication number
- GB0105893D0 GB0105893D0 GBGB0105893.2A GB0105893A GB0105893D0 GB 0105893 D0 GB0105893 D0 GB 0105893D0 GB 0105893 A GB0105893 A GB 0105893A GB 0105893 D0 GB0105893 D0 GB 0105893D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- active compounds
- pharmaceutically active
- pharmaceutically
- compounds
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0105893.2A GB0105893D0 (en) | 2001-03-09 | 2001-03-09 | Pharmaceutically active compounds |
PCT/IB2002/000622 WO2002072586A1 (en) | 2001-03-09 | 2002-02-27 | Pyrazolo'4,3-d-pyrimidine for inhibiting cgmp pde |
US10/092,992 US20020173502A1 (en) | 2001-03-09 | 2002-03-06 | Pharmaceutically active compounds |
GT200200044A GT200200044A (en) | 2001-03-09 | 2002-03-06 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
PE2002000183A PE20021153A1 (en) | 2001-03-09 | 2002-03-07 | 5- [2-BUTOXY-5- (1-HYDROXYETHYL) -3-PYRIDINYL] -3-ETHYL-2- (1-ETHYL-3-AZETHYDINYL) -2,6-DIHYDRO-7H-PYRAZOLE [4,3- d] PYRIMIDIN-7-ONA AS INHIBITORS OF GUANOSIN 3 ', 5'-CYCLIC MONOPHOSPHATE PHOSPHODIESTERASES |
APAP/P/2002/002462A AP2002002462A0 (en) | 2001-03-09 | 2002-03-07 | Pharmaceutically active compounds. |
HN2002000050A HN2002000050A (en) | 2001-03-09 | 2002-03-08 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
TNTNSN02023A TNSN02023A1 (en) | 2001-03-09 | 2002-03-08 | PYRAZOLOPYRIMIDINE DERIVATIVES NOVEL cGMP-PDE INHIBITORS AND COMPOSITIONS CONTAINING THEM. |
PA20028541101A PA8541101A1 (en) | 2001-03-09 | 2002-03-08 | PHARMACEUTICALLY ACTIVE COMPOUNDS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0105893.2A GB0105893D0 (en) | 2001-03-09 | 2001-03-09 | Pharmaceutically active compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0105893D0 true GB0105893D0 (en) | 2001-04-25 |
Family
ID=9910362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0105893.2A Ceased GB0105893D0 (en) | 2001-03-09 | 2001-03-09 | Pharmaceutically active compounds |
Country Status (8)
Country | Link |
---|---|
AP (1) | AP2002002462A0 (en) |
GB (1) | GB0105893D0 (en) |
GT (1) | GT200200044A (en) |
HN (1) | HN2002000050A (en) |
PA (1) | PA8541101A1 (en) |
PE (1) | PE20021153A1 (en) |
TN (1) | TNSN02023A1 (en) |
WO (1) | WO2002072586A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
KR20070091049A (en) | 2002-12-13 | 2007-09-06 | 워너-램버트 캄파니 엘엘씨 | Alpha-2-delta ligand to treat lower urinary tract symptoms |
MXPA06000623A (en) * | 2003-07-16 | 2006-04-11 | Pfizer | Treatment of sexual dysfunction. |
JP2009503020A (en) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Use of flibanserin in the treatment of obesity |
WO2007048803A1 (en) | 2005-10-29 | 2007-05-03 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
JP2009541443A (en) | 2006-06-30 | 2009-11-26 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Flibanserin for the treatment of urinary incontinence and related diseases |
AU2007286288A1 (en) | 2006-08-14 | 2008-02-21 | Boehringer Ingelheim International Gmbh | Formulations of flibanserin and method for manufacturing the same |
BRPI0716436B8 (en) | 2006-08-25 | 2021-05-25 | Boehringer Ingelheim Int | controlled release system and method for manufacturing it |
CL2008002693A1 (en) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Use of flibanserin for the treatment of selected vasomotor symptoms of hot flashes, night sweats, mood swings, and irritability |
CA2686480A1 (en) | 2008-12-15 | 2010-06-15 | Boehringer Ingelheim International Gmbh | New salts |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE247117T1 (en) * | 1998-04-20 | 2003-08-15 | Pfizer | PYRAZOLOPYRIMIDINONE CGMP PDE5 INHIBITORS FOR THE TREATMENT OF SEXUAL FUNCTION DISORDERS |
GB9823101D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
PL357522A1 (en) * | 1999-10-11 | 2004-07-26 | Pfizer, Inc. | 5-(2-substituted-5-heterocyclylsulphonylpyrid-3-yl)-dihydropyrazolo[4,3-d]pyrimidin-7-ones as phosphodiesterase inhibitors |
CO5271697A1 (en) * | 2000-01-12 | 2003-04-30 | Pfizer Prod Inc | COMPOSITIONS AND PROCEDURES FOR THE TREATMENT OF AFFECTIONS THAT RESPOND TO AN INCREASE OF TESTOSTERONE |
-
2001
- 2001-03-09 GB GBGB0105893.2A patent/GB0105893D0/en not_active Ceased
-
2002
- 2002-02-27 WO PCT/IB2002/000622 patent/WO2002072586A1/en not_active Application Discontinuation
- 2002-03-06 GT GT200200044A patent/GT200200044A/en unknown
- 2002-03-07 PE PE2002000183A patent/PE20021153A1/en not_active Application Discontinuation
- 2002-03-07 AP APAP/P/2002/002462A patent/AP2002002462A0/en unknown
- 2002-03-08 PA PA20028541101A patent/PA8541101A1/en unknown
- 2002-03-08 TN TNTNSN02023A patent/TNSN02023A1/en unknown
- 2002-03-08 HN HN2002000050A patent/HN2002000050A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PA8541101A1 (en) | 2003-11-12 |
TNSN02023A1 (en) | 2005-12-23 |
AP2002002462A0 (en) | 2002-06-30 |
HN2002000050A (en) | 2002-09-13 |
GT200200044A (en) | 2002-12-02 |
PE20021153A1 (en) | 2002-12-17 |
WO2002072586A1 (en) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24411A (en) | Pharmaceutically active compounds | |
GB9924020D0 (en) | Pharmaceutically active compounds | |
IL146117A0 (en) | New pharmaceutically active compounds | |
HUP0400732A3 (en) | Pharmaceutically active uridine esters | |
GB0101227D0 (en) | Pharmaceutical compounds | |
GB0101225D0 (en) | Pharmaceutical compounds | |
GB0105893D0 (en) | Pharmaceutically active compounds | |
GB0107751D0 (en) | Pharmaceutically active compounds | |
GB0106631D0 (en) | Pharmaceutically active compounds | |
GB0112561D0 (en) | Active plate | |
GB0017822D0 (en) | Pharmaceutically active compound | |
GB0112563D0 (en) | Active plate | |
GB0219897D0 (en) | Pharmaceutically active compounds | |
GB0106629D0 (en) | Pharmaceutically active compounds | |
GB0106617D0 (en) | Pharmaceutically active compounds | |
GB0106651D0 (en) | Pharmaceutically active compounds | |
GB0106561D0 (en) | Pharmaceutically active compounds | |
GB0106562D0 (en) | Pharmaceutically active compounds | |
GB0219893D0 (en) | Pharmaceutically active compounds | |
GB0018656D0 (en) | Pharmaceutically active compounds | |
GB0007345D0 (en) | Pharmaceutically active compounds | |
GB0018660D0 (en) | Pharmaceutically active compounds | |
GB9926630D0 (en) | Pharmacologically active compounds | |
GB0219895D0 (en) | Pharmaceutically active compounds | |
GB0105766D0 (en) | Orally active compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |